EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease

被引：0
|
作者：
Juan Diego Alzate
Reed Mullen
Elad Mashiach
Kenneth Bernstein
Fernando De Nigris Vasconcellos
Lauren Rotmann
Assaf Berger
Tanxia Qu
Joshua S. Silverman
John G. Golfinos
Bernadine R. Donahue
Douglas Kondziolka
机构：
[1] New York University,Department of Neurological Surgery, NYU Langone Health
[2] New York University,Department of Radiation Oncology, NYU Langone Health
来源：
Journal of Neuro-Oncology | 2023年 / 164卷 / 2期
关键词：
Non-small cell lung cancer; Epidermal growth factor receptor; Tyrosine kinase inhibitor; Leptomeningeal disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 396
页数：9
相关论文
共 50 条
  • [21] How to Treat EGFR-Mutated Non-Small Cell Lung Cancer
    Belani, Neel
    Liang, Katherine
    Fradley, Michael
    Judd, Julia
    Borghaei, Hossein
    JACC: CARDIOONCOLOGY, 2023, 5 (04): : 542 - 545
  • [22] Safety of osimertinib in EGFR-mutated non-small cell lung cancer
    Mezquita, Laura
    Varga, Andreea
    Planchard, David
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1239 - 1248
  • [23] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [24] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Outcomes of KRAS mutated, EGFR mutated, ALK mutated and wildtype patients in non-small cell lung cancer brain metastases.
    Rauf, Yasmeen
    Tatineni, Vineeth
    Oshea, Patrick Joseph
    Jia, Xuefei
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?
    Leonetti, Alessandro
    Facchinetti, Francesco
    Tiseo, Marcello
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [27] High-dose furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, Haiyang
    Wang, Lili
    Wu, Yingxi
    Wu, Yufeng
    Ma, Shuxiang
    Yang, Sen
    He, Zhen
    Mo, Yuqing
    Zhang, Cuicui
    Wang, Qiming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in ALK and EGFR Driven Non-Small Cell Lung Cancer
    Robin, Tyler P.
    Camidge, D. Ross
    Stuhr, Kelly
    Nath, Sameer K.
    Breeze, Robert E.
    Pacheco, Jose M.
    Liu, Arthur K.
    Gaspar, Laurie E.
    Purcell, W. Thomas
    Doebele, Robert C.
    Kavanagh, Brian D.
    Rusthoven, Chad G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (05) : 715 - 720
  • [29] Long-term survival of a non-small cell lung cancer patient with EGFR-mutated brain metastases: a case report
    Wan, Yuming
    Xu, Feng
    Wang, Jin
    TRANSLATIONAL CANCER RESEARCH, 2022, : 4448 - 4454
  • [30] American Radium Society Appropriate Use Criteria for the Management of Brain Metastases in EGFR-mutated Non-Small Cell Lung Cancer
    Nagpal, Seema
    Chiang, Veronica
    Milano, Michael
    Soltys, Scott
    Ahluwalia, Manmeet
    Chao, Samuel
    Garg, Amit
    Gephart, Melanie
    Halasz, Lia
    Jabbari, Siavash
    Knisely, Jonathan
    Lo, Simon
    Palmer, Joshua
    Sahgal, Arjun
    Tom, Martin
    Wang, Tony
    Chang, Eric
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S49 - S50
12345